(Q41321872)

English

Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins

scientific article published on August 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 September 2017

Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins (English)

1 reference

Europe PubMed Central

29 September 2017

author name string

Azuma A

1

1 reference

Europe PubMed Central

29 September 2017

Yamano Y

2

1 reference

Europe PubMed Central

29 September 2017

Yoshimura A

3

1 reference

Europe PubMed Central

29 September 2017

Hibino T

4

1 reference

Europe PubMed Central

29 September 2017

Nishida T

5

1 reference

Europe PubMed Central

29 September 2017

Yagita H

6

1 reference

Europe PubMed Central

29 September 2017

Okumura K

7

1 reference

Europe PubMed Central

29 September 2017

Seya T

8

1 reference

Europe PubMed Central

29 September 2017

Kannagi R

9

1 reference

Europe PubMed Central

29 September 2017

Shibuya M

10

1 reference

Europe PubMed Central

29 September 2017

publication date

1 August 1995

1 reference

Europe PubMed Central

29 September 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

29 September 2017

42

1 reference

Europe PubMed Central

29 September 2017

202-208

1 reference

Europe PubMed Central

29 September 2017

2

1 reference

Europe PubMed Central

29 September 2017

Monoclonal antibodies in cancer detection and therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

A monoclonal antibody against human colonic adenoma recognizes difucosylated Type-2-blood-group chains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Human/mouse chimeric antibodies show low reactivity with human anti-murine antibodies (HAMA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Biological and Clinical Implications of Lymphocyte Hybridomas: Tumor Therapy with Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1995.TB03646.X

21 January 2018

Identifiers

10.1111/J.1365-3083.1995.TB03646.X

1 reference

Europe PubMed Central

29 September 2017

1 reference

Europe PubMed Central

29 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41321872&oldid=2095886720"